Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Varret

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Atherosclerosis Plus|March 30, 2026
PCSK9 in vascular smooth muscle cells: biology, pathology, and inhibition to fight atherosclerosisAlessio Amorosi, Mathilde Varret
Atherosclerosis|May 31, 2021
APOE gene variants in primary dyslipidemiaYara Abou Khalil, Jean-Pierre Rabès, Catherine Boileau, et al.
Current Genomics|September 3, 2013
Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian populationAwatef Jelassi, Mohamed Najah, Afef Slimani, et al.
Biochimica Et Biophysica Acta|September 5, 2006
DnaJA4 is a SREBP-regulated chaperone involved in the cholesterol biosynthesis pathwayCéline Robichon, Mathilde Varret, Xavier Le Liepvre, et al.
Current Atherosclerosis Reports|October 18, 2017
PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 TherapiesPetra El Khoury, Sandy Elbitar, Youmna Ghaleb, et al.
Human Mutation|February 5, 2009
Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and diseaseMarianne Abifadel, Jean-Pierre Rabès, Martine Devillers, et al.
Joint Bone Spine|January 26, 2010
Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndromeAlice Marques-Pinheiro, Régis Levasseur, Catherine Cormier, et al.
Expert Opinion on Therapeutic Patents|September 21, 2010
Strategies for proprotein convertase subtilisin kexin 9 modulation: a perspective on recent patentsMarianne Abifadel, Jihane Pakradouni, Matthieu Collin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 29, 2004
Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9Khadija Ouguerram, Maud Chetiveaux, Yassine Zair, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 5, 2021
Polymorphisms rs2745557 in PTGS2 and rs2075797 in PTGER2 are associated with the risk of chronic obstructive pulmonary disease development in a Tunisian cohortSalma Mani, Xavier Norel, Mathilde Varret, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Atherosclerosis Plus|March 30, 2026
PCSK9 in vascular smooth muscle cells: biology, pathology, and inhibition to fight atherosclerosisAlessio Amorosi, Mathilde Varret
Atherosclerosis|May 31, 2021
APOE gene variants in primary dyslipidemiaYara Abou Khalil, Jean-Pierre Rabès, Catherine Boileau, et al.
Current Genomics|September 3, 2013
Autosomal dominant hypercholesterolemia: needs for early diagnosis and cascade screening in the tunisian populationAwatef Jelassi, Mohamed Najah, Afef Slimani, et al.
Biochimica Et Biophysica Acta|September 5, 2006
DnaJA4 is a SREBP-regulated chaperone involved in the cholesterol biosynthesis pathwayCéline Robichon, Mathilde Varret, Xavier Le Liepvre, et al.
Current Atherosclerosis Reports|October 18, 2017
PCSK9 Mutations in Familial Hypercholesterolemia: from a Groundbreaking Discovery to Anti-PCSK9 TherapiesPetra El Khoury, Sandy Elbitar, Youmna Ghaleb, et al.
Human Mutation|February 5, 2009
Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and diseaseMarianne Abifadel, Jean-Pierre Rabès, Martine Devillers, et al.
Joint Bone Spine|January 26, 2010
Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndromeAlice Marques-Pinheiro, Régis Levasseur, Catherine Cormier, et al.
Expert Opinion on Therapeutic Patents|September 21, 2010
Strategies for proprotein convertase subtilisin kexin 9 modulation: a perspective on recent patentsMarianne Abifadel, Jihane Pakradouni, Matthieu Collin, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 29, 2004
Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9Khadija Ouguerram, Maud Chetiveaux, Yassine Zair, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|February 5, 2021
Polymorphisms rs2745557 in PTGS2 and rs2075797 in PTGER2 are associated with the risk of chronic obstructive pulmonary disease development in a Tunisian cohortSalma Mani, Xavier Norel, Mathilde Varret, et al.
Pageof 6